Business

Eurofins Successfully Prices New €500M 7.5-Year Senior Unsecured Bonds

LUXEMBOURG, July 29, 2025--Regulatory News: Eurofins (Paris:ERF):

articleEurofins Scientific SeJuly 29, 20254/company/eurofins-scientific-se-1/news/eurofins-successfully-prices-new-euro500m-75-year-senior-unsecured-bonds-1
Eurofins Successfully Prices New €500M 7.5-Year Senior Unsecured Bonds

About this update from Eurofins Scientific Se

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1518,"height":299,"url":"https://media.zenfs.com/en/business-wire.com/00d2c8930a81a6dc84551c4fd1112a6a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/vfj93bL39FtcupeuVOS8ww--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE4OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/00d2c8930a81a6dc84551c4fd1112a6a","width":960,"height":189},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/JbVtwRWVpglPEt12MeLEUQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NzI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/00d2c8930a81a6dc84551c4fd1112a6a","width":1200,"height":236}},"lazy":false},{"type":"text","content":"LUXEMBOURG, July 29, 2025--(BUSINESS WIRE)--Regulatory News:","length":60,"tagName":"p"},{"type":"text","content":"Eurofins (Paris:ERF):","length":21,"tagName":"p"},{"type":"text","content":"Eurofins Scientific (EUFI.PA, rated Baa3/stable by Moody’s and BBB-/stable by Fitch, "Eurofins"), a global leader in bioanalytical testing, announces that it has successfully raised €500m in its latest senior unsecured Euro-denominated public bond issuance (the "Bonds"). The Bonds have a 7.5-year maturity (due on 5 February 2033) and will bear an annual fixed rate coupon of 3.875%. The transaction was well received and was more than 8x over-subscribed.","length":476,"tagName":"p"},{"type":"text","content":"As communicated on 23 July 2025, the proceeds of the New Bond will be used to finance Eurofins’ planned acquisition of related party-owned sites in the second half of 2025 as well as for general corporate purposes.","length":214,"tagName":"p"},{"type":"text","content":"Comment from the CEO, Dr Gilles Martin: "We are very pleased with the results of our latest public bond issuance. This is a solid vote of confidence from investors in our approach to owning sites of long-term strategic interest to Eurofins and supports our objective of being the most productive, digital, innovative and customer-centric network of laboratories in the end markets and regions we serve."","length":413,"tagName":"p"},{"type":"text","content":"The Bonds will be listed from their issue date (5 August 2025) on the regulated market of the Luxembourg stock exchange (ISIN XS3135157298). The Bonds are not regis...

More updates from Eurofins Scientific Se

EurofinsSecurities Actglobal leaderentrepreneurial network